“We’re delighted to present Q-CROC’s activity report for 2023, reflecting the achievements and challenges of our network on this 15th year of our existence. Since 2008, Q-CROC has positioned itself as a key player in clinical oncology research in Quebec, bringing together over 40 healthcare institutions, research centers and partner organizations.
We invite you to peruse this report of our achievements, projects and prospects for 2024. We hope you’ll share our pride and enthusiasm for the work we’ve accomplished, and for the work that remains to be done. Together, we can make a difference to clinical oncology research in Quebec and Canada.“
– Jean-Frédéric Lafontaine (Chair) et Lucie D’Amours (General Manager)
We sincerely thank our 2023 financial partners whose support enabled the successful execution of our projects: AbbVie, Amgen, Bristol Meyers-Squibb, GlaxoSmithKline, Incyte, Innovative Medicines Canada, Merck, Pfizer and Roche.